Seasonal Respiratory Virus Circulation in a Tertiary Care Hospital in Greece

Abstract

Background: The COVID-19 pandemic caused by the novel SARS-CoV-2 virus affected health care systems and public health worldwide dramatically. Several measures were applied in order to prevent or stop the rapid transmission of the virus and the subsequent disease, such as lockdowns, physical distancing, strictly hygiene, along with travel restrictions. Global population after vaccination programs against COVID-19 were carried out, is facing a “tripledemic” situation threat, with the co-existance of SARS-CoV-2, influenza and RSV. The aim of the present study was to evaluate the co-existence of SARS-CoV-2, influenza and RSV, as well as the correlation with gender, age, Cts and vaccination doses. Methods: A total of 302 patients were included in the study. All patients were admitted to the emergency department of General Hospital Nikea, Piraeus with common upper respiratory tract symptoms and were suspected for COVID-19 disease, between March to July 2022. Patients’ age, gender, vaccination doses, and results from RT-PCR detection for SARS-CoV-2, RSV and Influenza viruses were recorded. Results: 139 were male and 163 female, aged between 18-94 years. Out of the patients included in the study, 206 were vaccinated and 96 were not vaccinated. Among vaccinated patients 97 were male and 109 were female. A percentage of 3.3% had received one vaccination dose, 16.9% two and 47.7% three. Moreover, 88 patients presented infection symptoms; 81 patients had a positive rapid test result. We detected 15 cases of co-infection of SaRS-CoV-2 and RSV and only one case, of co-infection of SaRS-CoV-2 with influenza virus. Conclusions: The majority of patients admitted to the emergency department of GHNP with common upper respiratory tract clinical manifestations were female. A significantly lower rate of co-infection with SARS-CoV-2 and RSV was detected in patients having received 2 vaccination doses, compared to patients having received 3 out of 3 vaccination doses or up to 1 vaccination dose. Ct values for SARS-CoV-2 and RSV pathogens were between 10-17. Co-infection with SARS-CoV-2 and Influenza was detected in only 1 patient.